These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 18593934)

  • 21. Mnt-deficient mammary glands exhibit impaired involution and tumors with characteristics of myc overexpression.
    Toyo-oka K; Bowen TJ; Hirotsune S; Li Z; Jain S; Ota S; Escoubet-Lozach L; Garcia-Bassets I; Lozach J; Rosenfeld MG; Glass CK; Eisenman R; Ren B; Hurlin P; Wynshaw-Boris A
    Cancer Res; 2006 Jun; 66(11):5565-73. PubMed ID: 16740691
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells.
    Sampson VB; Rong NH; Han J; Yang Q; Aris V; Soteropoulos P; Petrelli NJ; Dunn SP; Krueger LJ
    Cancer Res; 2007 Oct; 67(20):9762-70. PubMed ID: 17942906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Of Myc and Mnt.
    Hooker CW; Hurlin PJ
    J Cell Sci; 2006 Jan; 119(Pt 2):208-16. PubMed ID: 16410546
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low molecular weight inhibitors of Myc-Max interaction and function.
    Yin X; Giap C; Lazo JS; Prochownik EV
    Oncogene; 2003 Sep; 22(40):6151-9. PubMed ID: 13679853
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Translocations involving c-myc and c-myc function.
    Boxer LM; Dang CV
    Oncogene; 2001 Sep; 20(40):5595-610. PubMed ID: 11607812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Omomyc, a potential Myc dominant negative, enhances Myc-induced apoptosis.
    Soucek L; Jucker R; Panacchia L; Ricordy R; Tatò F; Nasi S
    Cancer Res; 2002 Jun; 62(12):3507-10. PubMed ID: 12067996
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Malignant transformation by overproduction of translation initiation factor eIF4G.
    Fukuchi-Shimogori T; Ishii I; Kashiwagi K; Mashiba H; Ekimoto H; Igarashi K
    Cancer Res; 1997 Nov; 57(22):5041-4. PubMed ID: 9371500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mad4 is regulated by a transcriptional repressor complex that contains Miz-1 and c-Myc.
    Kime L; Wright SC
    Biochem J; 2003 Feb; 370(Pt 1):291-8. PubMed ID: 12418961
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CCL5 promotes proliferation of MCF-7 cells through mTOR-dependent mRNA translation.
    Murooka TT; Rahbar R; Fish EN
    Biochem Biophys Res Commun; 2009 Sep; 387(2):381-6. PubMed ID: 19607806
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of the TAF4b gene is induced by MYC through a non-canonical, but not canonical, E-box which contributes to its specific response to MYC.
    Teye K; Okamoto K; Tanaka Y; Umata T; Ohnuma M; Moroi M; Kimura H; Tsuneoka M
    Int J Oncol; 2008 Dec; 33(6):1271-80. PubMed ID: 19020761
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Max network: coordinated transcriptional regulation of cell growth and proliferation.
    Eisenman RN
    Harvey Lect; 2000-2001; 96():1-32. PubMed ID: 12200869
    [No Abstract]   [Full Text] [Related]  

  • 32. Ectopic expression of myc or myn down-regulates immunoglobulin transcription.
    Sigvardsson M; Johansson K; Larsson LG; Nilsson K; Leanderson T
    Leukemia; 1994 Jul; 8(7):1157-63. PubMed ID: 8035607
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of murine Max (Myn) parallels the regulation of c-Myc in differentiating murine erythroleukemia cells.
    Dunn BK; Cogliati T; Cultraro CM; Bar-Ner M; Segal S
    Cell Growth Differ; 1994 Aug; 5(8):847-54. PubMed ID: 7986749
    [TBL] [Abstract][Full Text] [Related]  

  • 34. C-MYC: evidence for multiple regulatory functions.
    Penn LJ; Laufer EM; Land H
    Semin Cancer Biol; 1990 Feb; 1(1):69-80. PubMed ID: 2133113
    [TBL] [Abstract][Full Text] [Related]  

  • 35. c-Myc initiates illegitimate replication of the ribonucleotide reductase R2 gene.
    Kuschak TI; Kuschak BC; Taylor CL; Wright JA; Wiener F; Mai S
    Oncogene; 2002 Jan; 21(6):909-20. PubMed ID: 11840336
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting synthetic lethal interactions between Myc and the eIF4F complex impedes tumorigenesis.
    Lin CJ; Nasr Z; Premsrirut PK; Porco JA; Hippo Y; Lowe SW; Pelletier J
    Cell Rep; 2012 Apr; 1(4):325-33. PubMed ID: 22573234
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Id2 is dispensable for myc-induced lymphomagenesis.
    Nilsson JA; Nilsson LM; Keller U; Yokota Y; Boyd K; Cleveland JL
    Cancer Res; 2004 Oct; 64(20):7296-301. PubMed ID: 15492249
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cooperation of Gata3, c-Myc and Notch in malignant transformation of double positive thymocytes.
    van Hamburg JP; de Bruijn MJ; Dingjan GM; Beverloo HB; Diepstraten H; Ling KW; Hendriks RW
    Mol Immunol; 2008 Jun; 45(11):3085-95. PubMed ID: 18471881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Specific isoforms of translation initiation factor 4GI show differences in translational activity.
    Coldwell MJ; Morley SJ
    Mol Cell Biol; 2006 Nov; 26(22):8448-60. PubMed ID: 16982693
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of c-myc in cellular growth control.
    Schmidt EV
    Oncogene; 1999 May; 18(19):2988-96. PubMed ID: 10378694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.